BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 27130044)

  • 1. Androgen control of lipid metabolism in prostate cancer: novel insights and future applications.
    Butler LM; Centenera MM; Swinnen JV
    Endocr Relat Cancer; 2016 May; 23(5):R219-27. PubMed ID: 27130044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgens and the control of lipid metabolism in human prostate cancer cells.
    Swinnen JV; Verhoeven G
    J Steroid Biochem Mol Biol; 1998 Apr; 65(1-6):191-8. PubMed ID: 9699873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgens, lipogenesis and prostate cancer.
    Swinnen JV; Heemers H; van de Sande T; de Schrijver E; Brusselmans K; Heyns W; Verhoeven G
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):273-9. PubMed ID: 15663990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased lipogenesis in steroid-responsive cancer cells: mechanisms of regulation, role in cancer cell biology and perspectives on clinical applications.
    Swinnen JV
    Verh K Acad Geneeskd Belg; 2001; 63(4):321-33. PubMed ID: 11603058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Androgens and increased lipogenesis in prostate cancer. Cell biologic and clinical perspectives].
    Verhoeven G
    Verh K Acad Geneeskd Belg; 2002; 64(3):189-95; discussion 195-6. PubMed ID: 12238242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen action in the prostate gland.
    Yadav N; Heemers HV
    Minerva Urol Nefrol; 2012 Mar; 64(1):35-49. PubMed ID: 22402316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways.
    Vis AN; Schröder FH
    BJU Int; 2009 Aug; 104(4):438-48. PubMed ID: 19558559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of androgen-induced increase in lipid accumulation in prostate cancer cells.
    Sikkeland J; Lindstad T; Saatcioglu F
    Methods Mol Biol; 2011; 776():371-82. PubMed ID: 21796538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel lipogenic enzyme ELOVL7 is involved in prostate cancer growth through saturated long-chain fatty acid metabolism.
    Tamura K; Makino A; Hullin-Matsuda F; Kobayashi T; Furihata M; Chung S; Ashida S; Miki T; Fujioka T; Shuin T; Nakamura Y; Nakagawa H
    Cancer Res; 2009 Oct; 69(20):8133-40. PubMed ID: 19826053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen regulation of gene expression.
    Lamont KR; Tindall DJ
    Adv Cancer Res; 2010; 107():137-62. PubMed ID: 20399963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgens promote prostate cancer cell growth through induction of autophagy.
    Shi Y; Han JJ; Tennakoon JB; Mehta FF; Merchant FA; Burns AR; Howe MK; McDonnell DP; Frigo DE
    Mol Endocrinol; 2013 Feb; 27(2):280-95. PubMed ID: 23250485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer.
    Locke JA; Guns ES; Lubik AA; Adomat HH; Hendy SC; Wood CA; Ettinger SL; Gleave ME; Nelson CC
    Cancer Res; 2008 Aug; 68(15):6407-15. PubMed ID: 18676866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen-regulated metabolism and biosynthesis in prostate cancer.
    Barfeld SJ; Itkonen HM; Urbanucci A; Mills IG
    Endocr Relat Cancer; 2014 Aug; 21(4):T57-66. PubMed ID: 24497572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of androgen deprivation therapy on dihydrotestosterone levels in the prostatic tissue of patients with prostate cancer.
    Nishiyama T; Hashimoto Y; Takahashi K
    Clin Cancer Res; 2004 Nov; 10(21):7121-6. PubMed ID: 15534082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into the androgen biotransformation in prostate cancer: A regulatory network among androgen, androgen receptors and UGTs.
    Qin X; Liu M; Wang X
    Pharmacol Res; 2016 Apr; 106():114-122. PubMed ID: 26926093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-prostatic androgen levels during various androgen-blockade regimens.
    Nishiyama T
    Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):229-41. PubMed ID: 18471782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen action in prostate cancer.
    Basu S; Tindall DJ
    Horm Cancer; 2010 Oct; 1(5):223-8. PubMed ID: 21761368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex steroid hormone metabolism and prostate cancer.
    Soronen P; Laiti M; Törn S; Härkönen P; Patrikainen L; Li Y; Pulkka A; Kurkela R; Herrala A; Kaija H; Isomaa V; Vihko P
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):281-6. PubMed ID: 15663991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen signaling and its interactions with other signaling pathways in prostate cancer.
    Kaarbø M; Klokk TI; Saatcioglu F
    Bioessays; 2007 Dec; 29(12):1227-38. PubMed ID: 18008377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgens and androgen receptor signaling in prostate tumorigenesis.
    Zhou Y; Bolton EC; Jones JO
    J Mol Endocrinol; 2015 Feb; 54(1):R15-29. PubMed ID: 25351819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.